This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
eHealth (EHTH) Q4 Earnings Miss on Higher Operating Costs
by Zacks Equity Research
eHealth (EHTH) expects revenues to be in the range of $450-$475 million in 2024.
ProAssurance (PRA) Incurs Q4 Loss on High Costs & Low Premium
by Zacks Equity Research
ProAssurance (PRA) continues to witness growth in net investment income due to the high interest rate environment.
Allstate (ALL) Rewards Shareholders With a 3.4% Dividend Hike
by Zacks Equity Research
Allstate's (ALL) dividend yield currently stands at 2.3% compared with the industry average of 0.3%.
Why Is Brown & Brown (BRO) Up 4.8% Since Last Earnings Report?
by Zacks Equity Research
Brown & Brown (BRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Finance Stocks Lagging Brown & Brown (BRO) This Year?
by Zacks Equity Research
Here is how Brown & Brown (BRO) and Assurant (AIZ) have performed compared to their sector so far this year.
CNO Financial (CNO) Q4 Earnings Beat on High Investment Income
by Zacks Equity Research
CNO Financial (CNO) anticipates the effective tax rate for 2024 to be around 23%.
AON's Q4 Earnings Miss on Higher Expenses, '23 FCF Jumps 5%
by Zacks Equity Research
AON expects interest expenses for first-quarter 2024 to be $120 million.
5 Insurance Brokers to Watch on Increased Business Activity
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
Why Brown & Brown (BRO) Stock Might be a Great Pick
by Zacks Equity Research
Brown & Brown (BRO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Arthur J. Gallagher (AJG) Q4 Earnings & Revenues Top, Up Y/Y
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results reflect higher adjusted revenues and margin expansion across the Brokerage and Risk Management segments.
Marsh & McLennan (MMC) Q4 Earnings Beat on Solid US Business
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results benefit from expanding operations across Latin America and EMEA, partly offset by higher operating expenses.
W.R. Berkley's (WRB) Q4 Earnings Beat on Higher Premiums
by Zacks Equity Research
W.R. Berkley's (WRB) Q4 results reflect higher premiums, a rise in the core portfolio, increased underwriting income and an improvement in the loss ratio.
The Zacks Analyst Blog Highlights Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson
by Zacks Equity Research
Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson are included in this Analyst Blog.
Top Research Reports for Novartis, Amgen & Palo Alto Networks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Amgen Inc. (AMGN) and Palo Alto Networks, Inc. (PANW).
Progressive's (PGR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Progressive's (PGR) fourth-quarter 2023 results reflect year-over-year improvement in the top line.
Brown & Brown's (BRO) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Brown & Brown's (BRO) Q4 results reflect strong organic growth, improved EBITDAC margin and higher net investment income, as well as lower expenses.
Here's What Key Metrics Tell Us About Brown & Brown (BRO) Q4 Earnings
by Zacks Equity Research
Although the revenue and EPS for Brown & Brown (BRO) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Arthur J. Gallagher (AJG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insights Into Brown & Brown (BRO) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Brown & Brown (BRO) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Arthur J. Gallagher (AJG) Buys MGB, Boosts Medical Reinsurance
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of MGB is set to enhance the growth of its medical reinsurance business and expand service offerings.
Marsh & McLennan (MMC) Up 14% in a Year: Upside Potential Left?
by Zacks Equity Research
Growth in the Latin America and Asia regions is expected to buoy Marsh & McLennan's (MMC) results.
Brown & Brown (BRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brown & Brown (BRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Bet on Brown & Brown (BRO) Now
by Zacks Equity Research
Brown & Brown (BRO) stands to gain from robust new businesses, premium rate increases across the majority of business lines, expansion initiatives, strategic buyouts and a strong financial position.
Arthur J. Gallagher (AJG) Adds Koberich to its Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Koberich is set to help it consolidate its presence in Europe.
Here's Why Hold Strategy is Apt for Willis Towers (WTW) Now
by Zacks Equity Research
Willis Towers (WTW) stands to gain from growth across the global lines of business, strategic inorganic expansion, higher demand for products and advisory work and a solid balance sheet.